synthet
analogu
bradykinin
potenti
nonapeptid
bpp
indic
significantli
differ
structur
requir
potenti
bradykinin
bk
induc
smooth
muscl
contract
gpi
inhibit
isol
somat
angiotensin
iconvert
enzym
ace
result
disprov
ace
inhibit
singl
mechan
also
direct
interact
potenti
peptid
bradykinin
receptor
transfect
cell
molecular
mechan
potenti
result
indic
stimul
inositol
phosphat
ip
n
format
independ
b
receptor
furthermor
result
la
support
role
extracellular
ca
influx
correspond
channel
miss
effect
calyculin
gpi
disprov
role
phosphatas
potenti
action
experiment
studi
contribut
better
understand
potenti
mechan
also
incorpor
shift
research
toward
immun
system
particular
toward
immunocompet
polymorphonuclear
leukocyt
chemotaxi
cell
potenti
like
exclus
inhibit
enzymat
degrad
bradykinin
thu
obtain
result
give
evid
potenti
bradykinin
action
occur
differ
mechan
depend
system
appli
potenti
factor
hormon
action
potenti
differ
factor
interact
receptor
enzymat
degrad
signal
pathway
howev
entir
overal
process
studi
detail
hormon
least
year
ago
potenti
action
observ
nonapeptid
hormon
bradykinin
bk
inde
histori
bk
isol
character
long
close
relat
use
potenti
factor
werl
cowork
use
snake
venom
trigger
format
bk
plasma
describ
tissu
hormon
function
immedi
isol
chemic
character
synthesi
function
character
certain
snake
venom
describ
bradykinin
potenti
compound
kato
suzuki
ferreira
et
al
ondetti
et
al
isol
differ
oligopeptid
bradykinin
potenti
activ
venom
two
snake
agkistrodon
hali
blomhoffii
bothrop
jararaca
includ
bradykinin
potenti
nonapeptid
bpp
trade
name
teprotid
bradykinin
potenti
peptid
also
isol
snake
toxin
well
recent
new
potenti
peptid
isol
venom
b
jararaca
surprisingli
peptid
potenti
activ
also
form
partial
hydrolysi
protein
taken
serum
hemoglobin
milk
wheat
germ
also
degrad
fragment
angiotensin
heptapeptid
found
potenti
bk
action
addit
linear
bk
analogu
partial
sequenc
certain
activ
inact
side
chain
backbon
cyclic
agonist
abl
potenti
bk
action
gpi
angiotensin
iconvert
enzym
ace
cleav
dipeptid
cterminu
angiotensin
bradykinin
result
one
hand
format
highli
hypertens
hormon
angiotensin
ii
hand
inactiv
hypotens
bk
enzym
extens
studi
import
function
blood
pressur
regul
ace
contain
ntermin
well
ctermin
catalyt
domain
describ
public
slight
differ
structur
requir
recent
cotton
et
al
demonstr
excel
investig
use
domainspecif
substrat
inhibitor
affin
differ
nand
ctermin
catalyt
domain
three
order
magnitud
membran
bound
form
enzym
seem
play
import
role
potenti
bk
action
inhibitor
enzym
use
drug
treatment
differ
form
hypertens
heart
failur
therapeut
use
hormon
knowledg
potenti
compound
action
mechan
import
knowledg
help
improv
therapeut
effect
prevent
excess
dose
also
interact
drug
side
effect
hand
therapeut
use
potenti
compound
requir
knowledg
interact
hormon
action
molecular
basi
well
shown
li
et
al
ace
may
also
act
receptor
sar
coronaviru
extens
therapeut
applic
bradykinin
potenti
compound
captopril
enalaprilat
ramiprilat
quinaprilat
lisinopril
studi
molecular
action
mechan
becom
import
mani
proteas
also
abl
inactiv
bk
includ
neutral
endopeptidas
nep
neprolysin
ec
potenti
bk
action
also
studi
vivo
model
pharmacolog
test
isol
organ
cellular
level
biochem
method
vivo
model
potenti
bk
action
measur
pressor
respons
intraven
bk
consciou
rabbit
hypotens
effect
freeli
move
wistar
rat
isol
organ
guinea
pig
ileum
gpi
rat
heart
rabbit
jugular
vein
cerebr
microvasculatur
estim
permeabl
porcin
coronari
arteri
use
vitro
test
yet
even
onset
search
molecular
mechan
bk
potenti
certain
contradictori
find
observ
inhibit
ace
variou
peptid
nonpeptid
compound
correl
well
potenti
activ
furthermor
maximum
bkinduc
contract
guinea
pig
ileum
enhanc
potenti
compound
also
action
evok
enzymat
stabl
bk
agonist
potenti
test
system
repeat
exposur
porcin
coronari
arteri
bk
led
receptor
desensit
addit
potenti
compound
quinaprilat
angiotensin
fulli
restor
relax
effect
point
bk
alon
longer
abl
induc
relax
molecular
level
coimmunoprecipit
ace
b
receptor
anti
receptor
antibodi
clearli
indic
interact
partner
cell
membran
despit
contradictori
degre
confus
find
regoli
cowork
dendorf
et
al
demonstr
test
system
rabbit
isol
aorta
venoconstrict
potenti
therapeut
use
ace
inhibitor
result
exclus
inhibit
enzymat
bk
degrad
nevertheless
group
regoli
found
influenc
ace
inhibitor
resensit
rabbit
jugular
vein
chang
densiti
b
receptor
rat
spinal
cord
understand
molecular
basi
discrep
mani
approach
undertaken
elucid
influenc
potenti
compound
differ
bradykinin
destroy
enzym
bradykinin
receptor
bkr
signal
pathway
direct
interact
potenti
compound
postul
b
receptor
phosphoryl
receptor
protein
kinas
c
lead
intern
desensit
dephosphoryl
phosphatas
resensit
bradykinin
potenti
factor
influenc
desensit
resensit
well
heterooligomer
b
receptor
includ
interact
ace
degrad
enzym
level
signal
pathway
crosstalk
pathway
induc
hormon
nonreceptormedi
intracellular
reaction
observ
initi
experiment
potenti
bradykinin
action
primarili
perform
isol
smooth
muscl
organ
last
decad
potenti
activ
mainli
investig
affin
densiti
receptor
intracellular
mobil
ca
releas
arachidon
acid
inositol
phosphat
nitric
oxid
later
studi
molecular
basi
bradykininevok
action
perform
cell
cultur
instead
smooth
muscl
studi
use
primarili
chines
hamster
ovari
cell
cho
cell
cotransfect
b
receptor
ace
acemut
neutral
endopeptidas
nep
endotheli
cell
use
constitut
express
b
receptor
ace
aim
experi
contribut
better
understand
potenti
mechan
prove
disprov
postul
action
mechan
studi
use
three
differ
system
smooth
muscl
contract
transient
transfect
cell
polymorphonuclear
leucocyt
began
find
differ
ace
inhibit
potenti
bk
action
interest
determin
role
ca
uptak
extracellular
sourc
releas
sarcoplasmat
reticulum
potenti
action
test
direct
interact
b
receptor
cell
check
influenc
potenti
peptid
receptor
dephosphoryl
select
signal
transduct
reaction
sinc
bk
play
import
role
inflammatori
process
studi
potenti
immunocompet
polymorphonuclear
leucocyt
howev
aim
verifi
negat
contradictori
opinion
regard
mechan
bradykinin
potenti
would
also
like
show
simultan
exist
differ
mechan
depend
assay
potenti
factor
use
boc
fmocand
ddzamino
acid
purchas
bachem
switzerland
orpegenpharma
germani
bocproocroh
synthes
accord
gener
procedur
publish
goth
et
al
form
hycram
tm
linker
hydroxycroton
ester
coupl
aminomethyl
resin
tentagelsnh
use
resin
purchas
follow
compani
amino
methyl
polystyren
tentagelsnh
wang
resin
rapp
polymer
germani
chlorotrityl
resin
novabiochem
germani
peptid
synthes
automat
synthes
appli
protein
technolog
usa
semiautomat
synthes
bachem
switzerland
step
monitor
kaiser
test
coupl
carri
neutral
repeat
wash
time
resin
diea
dcm
twofold
excess
n
protect
amino
acid
diisopropylcarbodiimid
dic
dcm
h
tetrafluorobor
tbtu
hobt
bocor
fmocprotect
amino
acid
use
fourfold
excess
solv
dmf
dcm
dmf
tbtu
hobt
appli
excess
diisopropylethylamin
diea
sixfold
excess
reaction
time
h
deprotect
procedur
bocdeprotect
perform
tfadcm
without
scaveng
two
step
min
treatment
follow
wash
dcm
second
treatment
min
ddzdeprotect
carri
tfa
dcm
two
step
min
fmocdeprotect
achiev
piperidin
dmf
two
step
min
ileum
cm
guinea
pig
suspend
ml
organ
bath
contain
tyrod
solut
c
isoton
contract
record
rest
tension
mg
bk
appli
concentr
correspond
ed
ed
bk
experiment
condit
gener
effect
increas
twice
bpp
nm
use
standard
bradykinin
potenti
peptid
ace
inhibitor
given
min
applic
bk
potenti
effect
analogu
calcul
per
cent
bkinduc
contract
compar
effect
caus
bpp
experi
investig
influenc
ca
bkpotenti
action
bpp
nm
bk
nm
bpp
la
mm
use
inhibitor
ca
influx
ca
free
ca
contain
tyrod
solut
lacl
alway
given
min
bkinduc
contract
applic
bpp
see
fig
calyculin
nm
use
estim
involv
bkinduc
nm
bk
potenti
nm
bk
nm
bpp
contract
guinea
pig
ileum
calyculin
appli
bpp
given
maximum
bkinduc
contract
min
bkand
bppinduc
effect
elicit
see
fig
inhibitori
activ
determin
enzym
prepar
guinea
pig
lung
use
benzoylglyhisleu
substrat
method
describ
elsewher
cell
cultur
transfect
cell
describ
detail
cell
atcc
routin
grown
dulbecco
modifi
eagl
medium
dmem
contain
vv
fetal
calf
serum
antibiot
kept
humidifi
co
air
atmospher
subconflu
cell
transfect
plate
bkrb
cdna
g
cdnawel
deaedextran
techniqu
cell
use
h
transfect
prepar
membran
done
describ
previous
competit
bind
studi
perform
use
thereaft
sampl
filter
whatman
gfb
glass
fiber
filter
pretreat
wv
aqueou
polyethylenimin
filter
wash
three
time
ml
icecold
bind
buffer
transfer
scintil
vial
dri
analyz
bound
radioact
scintil
count
cell
transfect
label
ciml
h
arachidon
acid
cimmol
nen
life
scienc
product
usa
h
describ
previous
cell
wash
three
time
labelfre
dmem
contain
vv
fetal
calf
serum
stimul
ml
medium
bk
min
absenc
presenc
c
assay
termin
remov
medium
cell
medium
measur
h
arachidon
acid
releas
scintil
count
heparin
venou
blood
healthi
volunt
mix
dextran
sulphat
nacl
ratio
vv
left
min
c
erythrocyt
sediment
occur
leukocyterich
plasma
layer
equal
volum
gradient
centrifug
min
g
contamin
erythrocyt
elimin
lysi
ammonium
chlorid
pure
pmn
wash
twice
eagl
minim
essenti
medium
mem
resuspend
pmnml
chemotaxi
quantifi
use
boyden
chamber
techniqu
describ
previous
pmn
suspend
eagl
mem
contain
mm
hepe
ph
ml
pipet
top
boyden
chamber
separ
pore
filter
sartoriu
sm
lower
part
peptid
put
lower
stimulu
compart
inhibitor
potenti
peptid
appli
pmn
min
c
upper
compart
chamber
incub
period
h
c
atmospher
co
air
high
humid
filter
fix
stain
methylen
blue
use
imag
analyz
chemotaxi
analyz
hasotec
rostock
germani
pmn
count
everi
interv
origin
monolay
distal
surfac
high
power
field
duplic
filter
averag
locomot
index
li
quantifi
express
migrat
index
comparison
control
control
mostli
valu
present
mean
sem
statist
analysi
evalu
student
ttest
independ
sampl
pair
sampl
depend
experiment
protocol
detail
describ
legend
figur
bpp
varieti
analogu
synthes
accord
three
differ
strategi
scheme
solid
phase
prevent
dioxopiperazin
format
chlorotrityl
resin
hycram
tm
resin
use
case
cltrityl
resin
cycliz
ctermin
dipeptid
avoid
steric
hindranc
resin
use
bocstrategi
hycram
tm
resin
prevent
ring
format
therebi
loss
load
synthes
wang
resin
provid
low
yield
remov
resin
peptid
purifi
semiprepar
hplc
chemic
character
analogu
prepar
photoaffin
label
bind
protein
inhibitori
activ
analogu
list
tabl
determin
isol
ace
guinea
pig
lung
organ
particularli
guinea
pig
ileum
contain
differ
bk
degrad
enzym
use
organ
homogen
estim
inhibit
bk
degrad
use
isol
ace
test
inhibit
hydrolysi
synthet
tripeptid
substrat
potenti
peptid
shown
tabl
distinct
differ
exist
potenti
bkinduc
contract
guinea
pig
ileum
inhibit
isol
ace
quantifi
differ
calcul
quotient
activ
analogu
bpp
quotient
account
distinct
differ
found
nonapeptid
analogu
partial
sequenc
label
azidosalicyl
acid
asa
quotient
reach
thu
compound
show
potenti
compar
bpp
enrich
inhibit
ace
analogu
higher
concentr
requir
result
quotient
one
earliest
pharmacolog
test
use
bradykinin
contract
isol
guinea
pig
ileum
gpi
test
contract
gpi
potenti
bpp
ace
inhibitor
ramiprilat
well
potenti
enhanc
isoton
measur
contract
min
preincub
fig
pd
valu
bk
shift
presenc
nm
bpp
n
n
ramiprilat
nm
n
potenti
also
abl
shift
cumul
gpi
contract
curv
enzymat
stabl
bradykinin
analogu
dargargprohypglythiserproabu
arg
higher
affin
pd
valu
bk
analogu
shift
bpp
nm
n
n
ramiprilat
n
studi
influenc
bradykinin
potenti
peptid
bradykinin
b
receptor
cell
transfect
scheme
strategi
synthesi
bpp
analogu
use
differ
linker
resin
wang
resin
chlorotrityl
resin
hycram
tm
resin
differ
protect
group
combin
tabl
analogu
bradykinin
potenti
peptid
bpp
teprotid
distinct
differ
potenti
bkinduc
contract
isol
guinea
pig
ileum
gpi
inhibit
isol
angiotensin
iconvert
enzym
ace
aminoacid
sequenc
potenti
aceinhibit
ic
gene
human
receptor
express
chemic
function
character
express
receptor
describ
preced
public
radioligand
bind
studi
tritium
label
bradykinin
h
bk
perform
intact
cell
fig
lanthanium
ion
la
act
inhibitor
uptak
ca
extracellular
space
use
la
estim
influenc
bpp
ca
uptak
bk
induc
contract
gpi
presenc
extracellular
calcium
ion
lowest
extracellular
concentr
ca
necessari
detect
contract
mm
ca
contain
tyrod
buffer
bk
induc
contract
isol
gpi
also
potenti
presenc
mm
la
fig
bradykinin
alon
unabl
contract
gpi
presenc
la
ileum
contract
addit
bpp
shown
part
fig
part
b
figur
reflect
result
ca
free
tyrod
buffer
clearli
underlin
import
role
extracellular
ca
bkinduc
smooth
muscl
contract
part
also
show
evid
mobil
intracellular
ca
necessari
potenti
peptid
bradykinin
induc
format
inositol
phosphat
cell
transient
express
bk
receptor
analogu
potenti
nonapeptid
abl
augment
bkinduc
intracellular
concentr
inositol
phosphat
rather
seem
reduc
bkinduc
ip
n
format
strike
result
fig
signific
enhanc
basal
level
potenti
peptid
absenc
bradykinin
possibl
indic
nonreceptormedi
pathway
bradykinin
trigger
releas
h
label
arachidon
acid
label
phospholipid
presum
activ
phospholipas
g
protein
level
arachidon
acid
significantli
enhanc
bk
shown
fig
potenti
peptid
slightli
significantli
enhanc
bkmediat
releas
label
arachidon
acid
without
bk
peptid
signific
influenc
basal
level
desensit
resensit
process
receptor
level
elicit
cytosol
receptor
phosphoryl
follow
intern
dephosphoryl
follow
reintegr
cell
membran
dephosphoryl
cytosol
serand
thrresidu
bk
receptor
result
activ
protein
phosphatas
calyculin
known
potent
inhibitor
protein
phosphatas
use
inhibitor
check
involv
phosphatas
potenti
bradykinin
action
fig
illustr
calyculin
influenc
potenti
bkinduc
contract
applic
calyculin
neither
bk
administr
chang
potenti
effect
bpp
ramiprilat
bradykinin
stimul
migrat
pmn
correspond
concentr
gradient
effect
could
character
true
chemotaxi
cell
contain
type
bk
receptor
bkrb
brkb
demonstr
use
bk
agonist
antagonist
migrat
assay
also
contain
complet
system
synthesi
releas
bioactiv
kinin
degrad
bk
proce
pmn
mainli
neutral
endopeptidas
nep
ec
bkinduc
acceler
migrat
pmn
potenti
preincub
min
cell
nep
inhibitor
phosphoramidon
migrat
index
mi
bk
significantli
p
ttest
pair
sampl
n
enhanc
presenc
phosphoramidon
mi
shown
migratori
capac
bk
pmn
also
potenti
ace
inhibitor
ramiprilat
migat
index
bk
without
ramiprilat
mi
presenc
ramiprilat
nm
mi
measur
six
experi
shown
shown
fig
bpp
enhanc
migrat
pmn
induc
well
bk
enzymat
stabl
bk
agonist
dargargprohypglythis
proabu
arg
unabl
enhanc
migratori
activ
nonpeptid
agonist
bkrb
agonist
desarg
bk
bpp
nm
abl
potenti
doserespons
curv
bkinduc
migrat
pmn
fig
potenti
bkinduc
effect
concentrationdepend
way
fig
potenti
action
despit
mani
long
year
experiment
research
investig
remain
phenomenon
fulli
understood
begin
studi
potenti
smooth
muscl
contract
year
ago
search
extend
organ
vascular
system
differ
bradykinin
degrad
enzym
immunocompet
cell
last
decad
molecular
mechan
level
bradykinin
receptor
signal
pathway
primarili
studi
cell
cultur
potenti
peptid
peptidomimet
besid
oligopeptid
isol
snake
venom
use
studi
gener
contradictori
find
therefor
explan
literatur
seem
result
complex
system
also
use
enzymat
fulli
stabl
bradykinin
agonist
eg
hyp
tyr
bk
speci
depend
bradykinin
receptor
differ
proteas
composit
tissu
cell
line
use
differ
studi
differ
structur
requir
catalyt
center
ace
furthermor
keep
mind
differ
densiti
bk
receptor
local
microdomain
plasma
membran
presenc
certain
hormon
receptor
differ
signal
pathway
use
tissu
cell
possibl
influenc
gprotein
independ
signal
transduct
gprotein
traffick
pattern
cell
activ
regul
gprotein
signal
ing
addit
potenti
effect
differenti
unspecif
specif
part
consequ
search
potenti
hormon
action
strongli
relat
recent
research
multifunct
signal
protein
isol
chemic
function
character
oligopeptid
taken
venom
differ
snake
provid
lead
structur
number
potenti
peptid
long
ago
oligopeptid
gave
evid
differ
structur
requir
potenti
smooth
muscl
contract
inhibit
ace
synthes
analogu
fragment
highli
activ
nonapeptid
bpp
show
case
differ
potenti
enzym
inhibit
five
order
magnitud
result
indic
strongli
differ
structur
requir
biolog
activ
inconsist
exclus
reduct
potenti
action
inhibit
ace
discuss
regoli
cowork
dendorf
et
al
might
draw
conclus
despit
differ
sourc
isol
organ
ace
sinc
bk
receptor
speci
depend
human
bkrb
share
sequenc
homolog
guinea
pig
wherea
ace
seem
nearli
speci
independ
interestingli
potenti
activ
much
less
influenc
amino
acid
replac
modif
lead
peptid
bpp
inhibit
ace
analogu
list
tabl
clearli
evid
potenti
gpi
contract
less
sensit
amino
acid
replac
modif
peptid
sequenc
inhibit
ace
thu
potenti
activ
vari
wherea
ic
valu
ace
inhibit
vari
activ
show
correl
estim
valu
indic
potenti
activ
allow
besid
amino
acid
replac
shorten
sequenc
well
substitut
nterminu
side
chain
aromat
moieti
inhibitori
activ
seem
depend
whole
sequenc
replac
basic
amino
acid
arg
posit
neutral
aliphat
aromat
amino
acid
influenc
ace
inhibit
slightli
hand
acyl
ly
side
chain
posit
asa
reduc
ic
valu
four
order
magnitud
accord
cotton
et
al
posit
seem
crucial
inhibitori
activ
result
provid
clear
structur
activ
relationship
discuss
potenti
bkinduc
contract
gpi
keep
mind
tissu
also
contain
proteas
ace
involv
bk
degrad
find
abl
explain
strong
differ
activ
express
ratio
tabl
reason
assum
interact
potenti
peptid
bk
receptor
interact
certain
possibl
mechan
exist
first
potenti
factor
could
act
like
alloster
effector
stabil
activ
receptor
conform
secondli
factor
could
influenc
phosphoryl
dephosphoryl
cytosol
part
receptor
result
desensit
resenzit
receptor
third
possibl
mechan
consist
influenc
potenti
factor
receptor
heterooligomer
abdalla
et
al
found
activ
high
affin
angiotensin
receptor
bkrb
abl
form
heteromer
complex
smooth
muscl
cell
importantli
heterodimer
evok
signal
enhanc
possibl
use
explan
potenti
effect
check
possibl
use
cell
transient
transfect
human
bkrb
displac
curv
show
differ
displac
h
bk
bk
alon
presenc
potenti
peptid
find
clearli
demonstr
analogu
bpp
use
studi
act
alloster
effector
stabil
activ
receptor
conform
cell
contain
ace
heterodimer
b
receptor
somat
ace
demonstr
erdo
marcic
imposs
system
radioligand
bind
curv
show
influenc
potenti
peptid
receptor
capac
indic
test
condit
number
intramembran
receptor
chang
result
exclud
intern
reintegr
receptor
influenc
potenti
peptid
would
exclud
process
heterodimer
ace
angiotensin
receptor
contract
smooth
muscl
requir
calcium
ion
consequ
potenti
bkinduc
contract
gpi
depend
extracellular
intracellular
ca
varieti
public
enhanc
intracellular
ca
level
use
qualit
quantit
proof
potenti
action
result
inhibit
ca
uptak
extracellular
sourc
la
indic
potenti
bkaction
requir
mobil
ca
intracellular
store
hand
begin
phase
bkevok
gpi
contract
extracellular
calcium
need
thu
result
la
agre
well
find
marcic
et
al
describ
inhibit
resensit
bk
receptor
cho
cell
la
inositol
phosphat
ip
n
form
transient
b
receptor
transfect
cell
open
ca
channel
endoplasmat
reticulum
lead
increas
cytosol
ca
potenti
nonapeptid
unabl
enhanc
bkinduc
format
ip
n
surprisingli
potenti
peptid
increas
basal
level
ip
n
absenc
bk
possibl
may
due
unspecif
nonreceptormedi
part
potenti
action
contrari
absent
effect
potenti
peptid
bkinduc
enhanc
inositol
phosphat
bkinduc
releas
arachidon
acid
significantli
increas
furthermor
contrari
ip
n
format
influenc
either
potenti
peptid
basal
level
could
found
continu
unabl
explain
potenti
arachidon
acid
releas
effect
receptor
detect
miss
effect
calyculin
potenti
might
indic
inhibit
phosphatas
involv
resensit
besid
gpi
cell
pmn
repres
third
system
studi
potenti
mechan
cell
constitut
express
b
well
b
receptor
cell
specif
set
proteas
involv
bk
degrad
system
potenti
nonapeptid
bpp
ramiprilat
acceler
bkinduc
migrat
contrast
ignjatov
et
al
found
cell
concentrationdepend
direct
activ
b
receptor
absenc
kinin
could
detect
activ
potenti
nonapeptid
without
administr
b
b
agonist
though
migratori
activ
proteolyt
stabil
bk
analogu
potenti
action
nonpeptid
agonist
could
acceler
bpp
ramiprilat
difficult
explain
find
agreement
weaker
acceler
stabil
bk
analogu
effect
nep
inhibitor
phosphoramidon
concentrationdepend
potenti
induc
bpp
might
suppos
test
system
potenti
occur
possibl
exclus
inhibit
enzymat
bk
degrad
also
consid
differ
mechan
peptid
nonpeptid
agonist
assumpt
support
test
strongli
reduc
intrins
activ
nonpeptid
agonist
compar
bk
last
three
decad
mani
differ
controversi
explan
potenti
mechan
deriv
experi
perform
vivo
vitro
cellular
level
distinct
case
signific
differ
inhibitori
potenti
activ
synthes
bpp
analogu
clearli
indic
opinion
guinea
pig
ileum
mechan
exclus
reduc
enzym
inhibit
observ
differ
even
exceed
differ
structur
requir
nand
ctermin
catalyt
center
ace
experi
la
gave
evid
potenti
smooth
muscl
contract
requir
extracellular
ca
taken
open
channel
increas
intracellular
level
inositol
phosphat
trigger
potenti
peptid
lead
addit
enhanc
intracellular
ca
concentr
applic
potenti
peptid
cell
transient
transfect
b
receptor
contain
endogen
ace
show
increas
receptor
affin
densiti
result
disprov
describ
suggest
direct
interact
bpp
bk
receptor
describ
receptor
resensit
potenti
peptid
could
result
dephosphoryl
activ
receptor
result
obtain
phosphatas
inhibitor
calyculin
disprov
influenc
bpp
calyculin
sensit
phosphatas
differ
potenti
neither
absenc
presenc
inhibitor
could
observ
releas
arachidon
acid
one
prerequisit
inflammatori
process
potenti
peptid
effect
basal
level
significantli
increas
bkinduc
releas
cell
result
indic
possibl
involv
potenti
peptid
inflammatori
process
without
affect
ace
contrari
mechan
potenti
migratori
activ
polymorphonuclear
leucocyt
seem
nearli
exclus
evok
ace
inhibit
b
b
receptor
contain
cell
direct
interact
b
receptor
could
observ
result
togeth
literatur
may
lead
gener
conclus
differ
potenti
factor
act
differ
organ
tissu
cell
differ
mechan
furthermor
bpp
evok
receptormedi
nonreceptormedi
intracellular
reaction
opinion
contradictori
explan
describ
potenti
mechan
result
one
hand
high
complex
kallikreinkinin
reninangiotensin
system
hand
differ
vivo
vitro
test
use
